Neonatal Screening: Cost-utility Analysis for Galactosemia

BACKGROUND: Galactosemia is a congenital metabolic disorder that can damage the health of a newborn. Screening is an important step to prevent and treat this condition. Due to increasing health care costs and limited financial resources of health systems, the most suitable economic analysis tool sho...

Descripción completa

Detalles Bibliográficos
Autores principales: HATAM, Nahid, ASKARIAN, Mehrdad, SHIRVANI, Samad, SIAVASHI, Elham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2017
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401919/
https://www.ncbi.nlm.nih.gov/pubmed/28451536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401919/
https://www.ncbi.nlm.nih.gov/pubmed/28451536

Ejemplares similares